(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tert-butoxy)butanoic acid is a protected, N-methylated derivative of the amino acid threonine. It features an N-terminal Fmoc (9-fluorenylmethoxycarbonyl) protecting group and a side-chain O-tert-butyl ether protection. The presence of the N-methyl group introduces conformational constraints and enhances metabolic stability in peptide sequences. This compound is a specialized, non-proteinogenic amino acid building block primarily used in solid-phase peptide synthesis (SPPS). The Fmoc group is selectively removable under basic conditions, allowing for sequential peptide chain elongation. The N-methylation reduces the number of hydrogen bond donors, often improving the bioavailability and membrane permeability of the resulting peptides. It is a critical reagent in the synthesis of complex peptides, peptidomimetics, and peptide-based drug candidates, particularly those requiring modified backbone structures. As a high-value, application-specific synthon, its primary market is in pharmaceutical research and development for constructing therapeutic peptides. It is not a commodity chemical and is handled as a fine chemical under standard laboratory safety protocols for organic compounds.